Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes

References

• LlovetJMVillanuevaALachenmayerAFinnRSAdvances in targeted therapies for hepatocellular carcinoma in the genomic eraNat Rev Clin Oncol201512740842426054909
   PubMed Web of Science ®Google Scholar
• LiLWangHHeterogeneity of liver cancer and personalized therapyCancer Lett2016379219119726213370
   PubMed Web of Science ®Google Scholar
• ZhuXTsend-AyushAYuanZGlycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapyInt J Pharm20175291–245146428698067
   PubMedGoogle Scholar
• NegishiMIrieANagataNIchikawaASpecific binding of glycyrrhetinic acid to the rat liver membraneBiochim Biophys Acta19911066177822065071
   PubMedGoogle Scholar
• HeZYZhengXWuXHDevelopment of glycyrrhetinic acid-modified stealth cationic liposomes for gene deliveryInt J Pharm20103971–214715420667672
   PubMed Web of Science ®Google Scholar
• ChenJJiangHWuYLiYGaoYA novel glycyrrhetinic acid-modified oxaliplatin liposome for liver-targeting and in vitro/vivo evaluationDrug Des Devel Ther2015922652275
   PubMed Web of Science ®Google Scholar
• YamaguchiHYuTKidachiYSelective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathioneBiochimie20119371172117821539886
   PubMed Web of Science ®Google Scholar
• ChenQDingHZhouJNovel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activitiesRSC Advance20166221778217791
   Web of Science ®Google Scholar
• TianJWangLWangLKeXA wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effectsDrug Deliv201421755355924215357
   PubMed Web of Science ®Google Scholar
• SunYQDaiCMZhengYShiSDHuHYChenDWBinding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cellsLife Sci201718818619128768154
   PubMed Web of Science ®Google Scholar
• LangerDCzarczynska-GoslinskaBGoslinskiTGlycyrrhetinic acid and its derivatives in infectious diseasesCurr Issues Pharm Med Sci2016293118123
   Google Scholar
• MahmoudAMAl DeraHS18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulationGenes Nutr20151064126386843
   PubMed Web of Science ®Google Scholar
• HasanSKSiddiqiANafeesSChemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2)Mol Cell Biochem20164161–216917727116616
   PubMed Web of Science ®Google Scholar
• KuangPZhaoWSuW18β-Glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in miceInt J Cancer201313281831184122991231
   PubMed Web of Science ®Google Scholar
• NoseMItoMKoideTTerawakiKOgiharaYThe effects of 18 alpha, beta-glycyrrhetinic acid on the hormonal induction of tyrosine aminotransferase in rat primary cultured hepatocytesPlanta Med19966254104128923804
   PubMed Web of Science ®Google Scholar
• Classen-HoubenDSchusterDDa CunhaTSelective inhibition of 11β-hydroxysteroid dehydrogenase 1 by 18α-glycyrrhetinic acid but not 18β-glycyrrhetinic acidJ Steroid Biochem Mol Biol20091133–524825219429429
   PubMed Web of Science ®Google Scholar
• ZongLQuYXuMYDongYWLuLG18α-glycyrrhetinic acid extracted from Glycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell lineJ Digest Dis2013146328336
   PubMed Web of Science ®Google Scholar
• ShettyAVThirugnanamSDakshinamoorthyG18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genesInt J Oncol201139363564021637916
   PubMed Web of Science ®Google Scholar
• IshidaSSakiyaYIchikawaTTairaZUptake of glycyrrhizin by isolated rat hepatocytesBiol Pharm Bull19931632932978364475
   PubMed Web of Science ®Google Scholar
• SongHSunYXuGHouBAoGSynthesis and biological evaluation of novel hydrogen sulfide releasing glycyrrhetic acid derivativesJ Enzyme Inhib Med Chem20163161457146326899462
   PubMed Web of Science ®Google Scholar
• SuXVickerNLawrenceHInhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivativesJ Steroid Biochem Mol Biol20071043–531232017493801
   PubMed Web of Science ®Google Scholar
• LinDZhongWLiJZhangBSongGHuTInvolvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growthNutr Cancer201466346347324547973
   PubMed Web of Science ®Google Scholar
• SunYLuJYanDShenLHuHChenDCellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid–modified liposome in hepatocellular carcinoma cellsEnviron Toxicol Pharmacol201753465628501784
   PubMed Web of Science ®Google Scholar
• ChuYLiDLuoYFHeXJJiangMYPreparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriersMolecules20141922445245724566313
   PubMed Web of Science ®Google Scholar
• TanCXiaSXueJXieJFengBZhangXLiposomes as vehicles for lutein: preparation, stability, liposomal membrane dynamics, and structureJ Agric Food Chem201361348175818423906192
   PubMed Web of Science ®Google Scholar
• ZhangJChangDYangYSystematic investigation on the intracellular trafficking network of polymeric nanoparticlesNanoscale2017993269328228225130
   PubMed Web of Science ®Google Scholar
• RoohbakhshAIranshahyMIranshahiMGlycyrrhetinic acid and its derivatives: anti-cancer and cancer chemopreventive properties, mechanisms of action and structure-cytotoxic activity relationshipCurr Med Chem201623549851726758798
   PubMed Web of Science ®Google Scholar
• MouldRBrownJMarshallFHLangmeadCJBinding kinetics differentiates functional antagonism of orexin-2 receptor ligandsBr J Pharmacol2014171235136323692283
   PubMed Web of Science ®Google Scholar
• AndarAUHoodRRVreelandWNDevoeDLSwaanPWMicro-fluidic preparation of liposomes to determine particle size influence on cellular uptake mechanismsPharm Res201431240141324092051
   PubMed Web of Science ®Google Scholar
• OchiMMAmoabedinyGRezayatSMAkbarzadehAEbrahimiBIn vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cellsCell J201618213514827540518
   PubMed Web of Science ®Google Scholar
• RanCChenDXuMDuCLiQJiangYA study on characteristic of different sample pretreatment methods to evaluate the entrapment efficiency of liposomesJ Chromatogr B Analyt Technol Biomed Life Sci201610285662
   PubMed Web of Science ®Google Scholar
• AwasthiVDGarciaDGoinsBAPhillipsWTCirculation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbitsInt J Pharm20032531–212113212593943
   PubMed Web of Science ®Google Scholar
• LópezOde la MazaACoderchLLópez-IglesiasCWehrliEParraJLDirect formation of mixed micelles in the solubilization of phospholipid liposomes by Triton X 100FEBS Lett199842633143189600258
   PubMed Web of Science ®Google Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
   PubMed Web of Science ®Google Scholar
• TianQWangXWangWZhangCLiuYYuanZInsight into glycyrrhetinic acid: the role of the hydroxyl group on liver targetingInt J Pharm20104001–215315720813176
   PubMedGoogle Scholar
• ShanLNear-infrared fluorescence 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR)-labeled macrophages for cell imaging. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]Bethesda, MDNational Center for Biotechnology Information (US)2004–20132009
   Google Scholar